Ngā hua rapu - Kohli, Payal
- E whakaatu ana i te 1 - 13 hua o te 13
-
1
-
2
-
3
-
4
Metabolic Markers to Predict Incident Diabetes Mellitus in Statin-Treated Patients (from the Treating to New Targets and the Stroke Prevention by Aggressive Reduction in Cholestero... mā Kohli, Payal, Knowles, Joshua W., Sarraju, Ashish, Waters, David D., Reaven, Gerald
I whakaputaina 2016Text -
5
Cost-Effective Medicines for Stroke Prophylaxis in Patients with Atrial Fibrillation mā Chakrabarti, Anjan K, Patel, Shalin J, Kohli, Payal, Udell, Jacob A, Singh, Priyamvada, Gopalakrishnan, Lakshmi, Kumar, Varun, Gibson, C Michael
I whakaputaina 2012Text -
6
Protectin D1 Is Generated in Asthma and Dampens Airway Inflammation and Hyperresponsiveness mā Levy, Bruce D., Kohli, Payal, Gotlinger, Katherine, Haworth, Oliver, Hong, Song, Kazani, Shamsah, Israel, Elliot, Haley, Kathleen J., Serhan, Charles N.
I whakaputaina 2007Text -
7
HIV and Hepatitis C–Coinfected Patients Have Lower Low‐Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent “PCSK9–Lipid Par... mā Kohli, Payal, Ganz, Peter, Ma, Yifei, Scherzer, Rebecca, Hur, Sophia, Weigel, Bernard, Grunfeld, Carl, Deeks, Steven, Wasserman, Scott, Scott, Rob, Hsue, Priscilla Y.
I whakaputaina 2016Text -
8
A Clinician's Guide to the ABCs of Cardiovascular Disease Prevention: The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease and American College of Cardiology Card... mā Hsu, Steven, Ton, Van‐Khue, Dominique Ashen, M., Martin, Seth S., Gluckman, Ty J., Kohli, Payal, Sisson, Stephen D., Blumenthal, Roger S., Blaha, Michael J.
I whakaputaina 2013Text -
9
Role of ST2 in Non–ST-Elevation Acute Coronary Syndrome in the MERLIN-TIMI 36 Trial mā Kohli, Payal, Bonaca, Marc P., Kakkar, Rahul, Kudinova, Anastacia Y., Scirica, Benjamin M., Sabatine, Marc S., Murphy, Sabina A., Braunwald, Eugene, Lee, Richard T., Morrow, David A.
I whakaputaina 2011Text -
10
Design and Rationale of the LAPLACE‐TIMI 57 Trial: A Phase II, Double‐Blind, Placebo‐Controlled Study of the Efficacy and Tolerability of a Monoclonal Antibody Inhibitor of PCSK9 i... mā Kohli, Payal, Desai, Nihar R., Giugliano, Robert P., Kim, Jae B., Somaratne, Ransi, Huang, Fannie, Knusel, Beat, McDonald, Shannon, Abrahamsen, Timothy, Wasserman, Scott M., Scott, Robert, Sabatine, Marc S.
I whakaputaina 2012Text -
11
Landmark Lipid‐Lowering Trials in the Primary Prevention of Cardiovascular Disease mā Chrispin, Jonathan, Martin, Seth S., Hasan, Rani K., Joshi, Parag H., Minder, C. Michael, McEvoy, John W., Kohli, Payal, Johnson, Amber E., Wang, Libin, Blaha, Michael J., Blumenthal, Roger S.
I whakaputaina 2013Text -
12
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LA... mā Giugliano, Robert P, Desai, Nihar R, Kohli, Payal, Rogers, William J, Somaratne, Ransi, Huang, Fannie, Liu, Thomas, Mohanavelu, Satishkumar, Hoffman, Elaine B, McDonald, Shannon T, Abrahamsen, Timothy E, Wasserman, Scott M, Scott, Robert, Sabatine, Marc S
I whakaputaina 2012Text -
13
Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention mā Kohli, Payal, Whelton, Seamus P., Hsu, Steven, Yancy, Clyde W., Stone, Neil J., Chrispin, Jonathan, Gilotra, Nisha A., Houston, Brian, Ashen, M. Dominique, Martin, Seth S., Joshi, Parag H., McEvoy, John W., Gluckman, Ty J., Michos, Erin D., Blaha, Michael J., Blumenthal, Roger S.
I whakaputaina 2014Text